$2.83
0.3514.11%
At close: -
$2.78
-0.05-1.77%
After Hours: 7:43 PM EDT
Comments
Loading...
HeartBeam (BEAT) Forecast
NewsEarningsHeartBeam (BEAT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHeartBeam (NASDAQ:BEAT) Stock Quotes, Forecast and News Summary
HeartBeam Stock (NASDAQ: BEAT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy HeartBeam (BEAT) stock?
You can purchase shares of HeartBeam (NASDAQ:BEAT) through any online brokerage.
Who are HeartBeam (BEAT) competitors?
Other companies in HeartBeam’s space includes: LENSAR (NASDAQ:LNSR), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD), Baird Medical Investment (NASDAQ:BDMD) and Lucid Diagnostics (NASDAQ:LUCD).
What is the forecast, or price target, for HeartBeam (BEAT) stock?
HeartBeam has a consensus price target of $6.78.
What is the current price for HeartBeam (BEAT)?
The stock price for HeartBeam (NASDAQ: BEAT) is $2.78 last updated November 21, 2024 at 7:43 PM EST.
Does HeartBeam (BEAT) pay a dividend?
There are no upcoming dividends for HeartBeam.
When is HeartBeam (NASDAQ:BEAT) reporting earnings?
HeartBeam’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is HeartBeam (BEAT) going to split?
There is no upcoming split for HeartBeam.
What sector and industry does HeartBeam (BEAT) operate in?
HeartBeam is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.